Abstract
Cisplatin is an important antineoplastic drug widely used against several tumors, especially those of the testis and ovaries (Prestayko et al. 1980). The dose-limiting side-effect of cisplatin chemotherapy is its nephrotoxicity, mainly consisting of degeneration of proximal tubules (Walker and Gale 1981); the mechanism of this nephrotoxicity is still unknown. Many attempts have been made to reduce cisplatin-induced nephrotoxicity. An interesting approach in this respect is the use of selenium. Selenium has been shown to prevent cadmium toxicity in animals (Parizek et al. 1974) and a protective effect of selenium against cisplatin lethality in mice has been described (Berry et al. 1984). It is not known how selenium exerts its protective effect against cisplatin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bakka A, Endresen L, Johnsen ABS, Edminson PD, Rugstad HE (1981) Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol 61: 215–226
Baldew GS, Van den Hamer CJA, de Goeij JJM, McVie JG (1987) Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats. (Manuscript in preparation)
Berry JP, Pauwells C, Tlouzeau S, Lespinats G (1984) Effect of selenium in combination with cis-diamminedichloroplatinum (II) in the treatment of murine fibrosarcoma. Cancer Res 44:2864–2868
Dunn MA, Blalock TL, Cousins RJ (1987) Minireview metallothionein. Proc Soc Exp Biol Med 185:107–119
Hoeschele JD, Butler TA, Roberts JA (1982) Analysis and refinement of the microscale synthesis of the 195mPt-labeled antitumor drug, cis-dichlorodiammineplatinum (II), cis-DDP. Radiochim Acta 31:27–36
Parizek J, Kalouskova J, Baliky A, Benes J, Pavlik L (1974) Interaction of selenium with mercury, cadmium and other toxic metals. In: Hoekstra WC, Suttie JW, Ganther HE, Mertz W (eds) Trace element metabolism in animals, vol. 2. University Park Press, Baltimore, pp 119–132
Prestayko AW, Crooke ST, Carter SK (eds) (1980) Cisplatin: current status and new developments. Academic, New York
Prins HW, van den Hammer CJA (1981) Comparative studies of copper metabolism in liver and kidney of normal and mutated brindled mice — with special emphasis on metallothionein. Comp Biochem Physiol [C]70:255–260
Walker EM, Gale GR (1981) Methods of reduction of cisplatin nephrotocitiy. Ann Clin Lab Sci 11:397–410
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag
About this paper
Cite this paper
Baldew, G.S., Volkers, K.J., Van den Hamer, C.J.A. (1988). Reduction of Cisplatin Nephrotoxicity by Selenium: Does Metallothionein Play a Role?. In: Chambers, P.L., Chambers, C.M., Dirheimer, G. (eds) The Target Organ and the Toxic Process. Archives of Toxicology, vol 12. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73113-6_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-73113-6_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18512-3
Online ISBN: 978-3-642-73113-6
eBook Packages: Springer Book Archive